On May 13, 2025, Hims & Hers Health, Inc. issued $1 billion in convertible senior notes due 2030, initially convertible into approximately 19.4 million shares at a conversion price of about $70.67 per share. The company also engaged in capped call transactions to mitigate potential dilution of shares upon conversion.